<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:mp ids='MP_0002959'>Microalbuminuria</z:mp> is considered the first clinical sign of kidney dysfunction and is associated with a poor renal and cardiovascular prognosis in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Detection of patients who are prone to develop micro- or macroalbuminuria may represent an effective strategy to start or optimise therapeutic intervention </plain></SENT>
<SENT sid="2" pm="."><plain>Here we assessed the value of a urinary proteomic-based risk score (classifier) in predicting the development and progression of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We conducted a prospective case-control study </plain></SENT>
<SENT sid="4" pm="."><plain>Cases (n = 44) and controls (n = 44) were selected from the PREVEND (Prevention of Renal and Vascular <z:e sem="disease" ids="C0679247" disease_type="Disease or Syndrome" abbrv="">End-stage Disease</z:e>) study and from the Steno <z:mp ids='MP_0002055'>Diabetes</z:mp> Center (Gentofte, Denmark) </plain></SENT>
<SENT sid="5" pm="."><plain>Cases were defined by transition from normo- to <z:mp ids='MP_0002959'>microalbuminuria</z:mp> or from micro- to macroalbuminuria over a follow-up of 3 years </plain></SENT>
<SENT sid="6" pm="."><plain>Controls with no transitions in <z:mp ids='MP_0002871'>albuminuria</z:mp> were pair-matched for age, sex and <z:mp ids='MP_0002871'>albuminuria</z:mp> status </plain></SENT>
<SENT sid="7" pm="."><plain>A model for the progression of <z:mp ids='MP_0002871'>albuminuria</z:mp> was built using a proteomic classifier based on 273 urinary <z:chebi fb="7" ids="16670">peptides</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: The proteomic classifier was independently associated with transition to micro- or macroalbuminuria (OR 1.35 [95% CI 1.02, 1.79], p = 0.035) </plain></SENT>
<SENT sid="9" pm="."><plain>The classifier predicted the development and progression of <z:mp ids='MP_0002871'>albuminuria</z:mp> on top of <z:mp ids='MP_0002871'>albuminuria</z:mp> and estimated GFR (eGFR, area under the receiver operating characteristic [ROC] curve increase of 0.03, p = 0.002; integrated discrimination index [IDI]: 0.105, p = 0.002) </plain></SENT>
<SENT sid="10" pm="."><plain>Fragments of collagen and α-2-HS-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> showed significantly different expression between cases and controls </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATION: Although limited by the relatively small sample size, these results suggest that analysis of a urinary biomarker set enables early renal risk assessment in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>Further work is required to confirm the role of urinary proteomics in the prevention of <z:hpo ids='HP_0000083'>renal failure</z:hpo> in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>